InsiderSignal.AI

InsiderSignal.ai

VRTX - Vertex Pharmaceuticals Inc / Ma

Insider Sale by Biller Jonathan (EVP, GC)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Biller Jonathan, serving as EVP, GC at Vertex Pharmaceuticals Inc / Ma (VRTX), sold 945 shares at $486.35 per share, for a total transaction value of $459,601.00. Following this transaction, Biller Jonathan now holds 13,659 shares of VRTX.

This sale represents a 6.00% decrease in Biller Jonathan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 25, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 1 day after the trade was made.

Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Biller Jonathan

EVP, GC

Jonathan Biller is the Executive Vice President and Chief Legal Officer at Vertex Pharmaceuticals, a position he has held since joining the company in 2022[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/jonathan-biller). In this role, he serves on the Executive Committee and oversees all aspects of the company's global legal and compliance functions[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/jonathan-biller). Biller earned his bachelor's degree in history from Brown University and his law degree from Yale Law School[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/jonathan-biller). Before joining Vertex, Biller held several senior legal and financial positions at Agios Pharmaceuticals, including Chief Legal Officer and Chief Financial Officer and Head of Legal and Corporate Affairs[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/jonathan-biller). His extensive executive experience also includes serving as Executive Vice President and General Counsel at Celgene, where he managed the global legal function, and as Senior Vice President of Tax and Treasury[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/jonathan-biller). Earlier in his career, he held leadership roles at Bunge Limited and Alcon, Inc., and began his legal practice at Hopkins & Sutter, where he rose to partner before joining Foley & Lardner following a firm merger[[1]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/jonathan-biller). As of mid-February 2026, Biller held approximately 20,819 shares of Vertex Pharmaceuticals stock[[2]](https://www.marketbeat.com/instant-alerts/jonathan-biller-sells-1925-shares-of-vertex-pharmaceuticals-nasdaqvrtx-stock-2026-02-12/).

View full insider profile →

Trade Price

$486.35

Quantity

945

Total Value

$459,601.00

Shares Owned

13,659

Trade Date

Wednesday, February 25, 2026

2 days ago

SEC Filing Date

Thursday, February 26, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Vertex Pharmaceuticals Inc / Ma

Company Overview

No company information available
View news mentioning VRTX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4326654

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime